Le syndrome d’apnée de sommeil. Est-il un facteur de risque de rétinopathie diabétique ?

Baba, Akira; Zbiba, W.; Bouayed, E.; Korbi, M.; Ghrairi, H.

doi:10.1016/j.jfo.2015.08.014

Cited by 9 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The diabetes management team should be aware of the main prognostic factors for increased risk of development and progression of sight-threatening DMO. This would enable the diabetes care team to identify high-risk patients at an early stage, for example, obesity, sleep apnoea, and elevated risk of progression of DR. 81 …”

Section: Introductionmentioning

confidence: 99%

Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease

Gale

Scanlon

Evans

et al. 2017

Eye

View full text Add to dashboard Cite

This paper identifies best practice recommendations for managing diabetes and sight-threatening diabetic eye disease. The authors provide an update for ophthalmologists and allied healthcare professionals on key aspects of diabetes management, supported by a review of the pertinent literature, and recommend practice principles for optimal patient management in treating visual impairment due to diabetic eye disease. In people with diabetes, early optimal glycaemic control reduces the long-term risk of both microvascular and macrovascular complications. The authors propose more can and should be done to maximise metabolic control, promote appropriate behavioural modifications and encourage timely treatment intensification when indicated to ameliorate diabetes-related complications. All people with diabetes should be screened for sight-threatening diabetic retinopathy promptly and regularly. It is shown that attitudes towards treatment adherence in diabetic macular oedema appear to mirror patients' views and health behaviours towards the management of their own diabetes. Awareness of diabetic macular oedema remains low among people with diabetes, who need access to education early in their disease about how to manage their diabetes to delay progression and possibly avoid eye-related complications. Ophthalmologists and allied healthcare professionals play a vital role in multidisciplinary diabetes management and establishment of dedicated diabetic macular oedema clinics is proposed. A broader understanding of the role of the diabetes specialist nurse may strengthen the case for comprehensive integrated care in ophthalmic practice. The recommendations are based on round table presentations and discussions held in London, UK, September 2016.

show abstract

Section: Introductionmentioning

confidence: 99%

Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease

Gale

Scanlon

Evans

et al. 2017

Eye

View full text Add to dashboard Cite

show abstract

Obstructive sleep apnea is not associated with diabetic retinopathy in diabetes: a prospective case–control study

et al. 2022

View full text Add to dashboard Cite

The Associations of Obstructive Sleep Apnea and Eye Disorders: Potential Insights into Pathogenesis and Treatment

Ahn

Gorin²

2021

Curr Sleep Medicine Rep

View full text Add to dashboard Cite

Purpose of Review Obstructive sleep apnea (OSA) patients are at significantly increased risks for cardiovascular and cerebrovascular morbidities. Recently, there has been heightened interest in the association of OSA with numerous ocular diseases and possible improvement of these conditions with the initiation of OSA treatment. We reviewed the current evidence with an emphasis on the overlapping pathogeneses of both diseases. Recent Findings Currently available literature points to a substantial association of OSA with ocular diseases, ranging from those involving the eyelid to optic neuropathies and retinal vascular diseases. Since the retina is one of the highest oxygen-consuming tissues in the body, the intermittent hypoxia and hypercapnia ensuing in OSA can have deleterious effects on ocular function and health. Tissue hypoxia, autonomic dysfunction, microvascular dysfunction, and inflammation all play important roles in the pathogenesis of both OSA and ocular diseases. Whether OSA treatment is capable of reversing the course of associated ocular diseases remains to be determined. It is anticipated that future therapeutic approaches will target the common underlying pathophysiologic mechanisms and promote favorable effects on the treatment of known associated ocular diseases. Summary Emerging evidence supports the association of ocular diseases with untreated OSA. Future studies focusing on whether therapeutic approaches targeting the common pathophysiologic mechanisms will be beneficial for the course of both diseases are warranted.

show abstract

Le syndrome d’apnée de sommeil. Est-il un facteur de risque de rétinopathie diabétique ?

Cited by 9 publications

References 16 publications

Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease

Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease

Obstructive sleep apnea is not associated with diabetic retinopathy in diabetes: a prospective case–control study

The Associations of Obstructive Sleep Apnea and Eye Disorders: Potential Insights into Pathogenesis and Treatment

Contact Info

Product

Resources

About